Skip to Main Content

Paper Details

Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer.
Ann Oncol
54
2007
Author NameAffiliation
Eleni AndreopoulouNew York University School of Medicine, NYU Cancer Institute
  • 1 - 1

Datasets

Release 1.2